SCHEMBL7794103

SCHEMBL7794103

COc1ccc2[nH]cc(CCNC(=O)CBr)c2c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 9/20 0.79
MTNR1B P49286 6/20 0.79
KMT2A Q03164 4/20 0.76
MEN1 O00255 3/20 0.76
ALDH1A1 P00352 2/20 0.76
KDM4E B2RXH2 1/20 0.76
CYP1A1 P04798 1/20 0.76
MPO P05164 1/20 0.76
CYP1A2 P05177 1/20 0.76
CYP3A4 P08684 1/20 0.76
HTR1A P08908 1/20 0.76
CYP2D6 P10635 1/20 0.76
HPGD P15428 1/20 0.76
NQO2 P16083 1/20 0.76
HTR2B P41595 1/20 0.76
RAB9A P51151 1/20 0.76
BLM P54132 1/20 0.76
PMP22 Q01453 1/20 0.76
CYP1B1 Q16678 1/20 0.76
NOTUM Q6P988 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29524586 0.89 MTNR1A (0.80) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL5612765 0.89 MTNR1A (0.80) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL29516731 0.88 MTNR1A (0.79) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL32678246 0.88 MTNR1A (0.79) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL5616635 0.88 MTNR1A (0.85) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL7794006 0.88 MTNR1A (1.00) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL7794072 0.88 MTNR1A (0.79) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL19261961 0.88 MTNR1A (0.80) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
SCHEMBL23644935 0.86 MTNR1A (0.83) MTNR1AMTNR1BKMT2AMEN1ALDH1A1
Melatonin SCHEMBL4686085 0.86 MTNR1A (1.00) MTNR1AMTNR1BKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0578620-B1 Pharmaceutical compositions for transdermal delivery of melatonin and/or its analogues I F L O S A S DI GIORGIO E ALD (IT) 2001-04-18 EP claimed
EP-0527687-B1 Novel arylethylamin derivatives, processes for their preparation and pharmaceutical compositions containing them ADIR (FR) 1995-11-22 EP disclosed
US-5380750-A Arylethylamine compounds ADIR ET COMPAGNIE (FR) 1995-01-10 US disclosed
US-5308866-A Treatment of melatonin related disorders, sleep disorders, psychological disorders ADIR ET COMPAGNIE (FR) 1994-05-03 US disclosed
US-5276051-A Treatment of melatoninergic system, antiischemic agents and skin disorders using aminoalkylindole compounds ADIR ET COMPAGNIE (FR) 1994-01-04 US disclosed
EP-0527687-A2 Novel arylethylamin derivatives, processes for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1993-02-17 EP disclosed